Volume: 9 Issue: 1
Year: 2021, Page: 59-63, Doi: https://doi.org/10.47799/pimr.0901.12
Received: Feb. 24, 2021 Accepted: March 2, 2021
Background: Diabetes mellitus is a multi-system disorder that affects many organs of the bodyincluding the lung. Thus, the lung is considered a 'target organ' in diabetes mellitus. Thepresent study is undertaken to evaluate the impact of type 2 diabetes mellitus onpulmonary functions of adult male diabetic patients and to compare between type 2diabetes mellitus patients and healthy adult male subjects.
Methods: Hundred adult male type 2 diabetic patients were selected from the diabetic clinic, Prathima Institute of Medical Sciences, Nagunur, Karimnagar, and 100 adult male healthy subjects were selected randomly among the general population from Karimnagar city. spirograms were recorded by Spirowin PC-basedSpirometer. Parameters such as Forced Vital Capacity (FVC), Forced ExpiratoryVolume in 1st second (FEV1), the ratio of FEV1/FVC, Forced Expiratory Flow (FEF) inthe Middle Half of FVC, and Peak Expiratory Rate (PEFR) were assessed and analyzedby using the paired t-test and ANOVA.
Results: Diabetes mellitus has a negative impact on pulmonary functions when compared with healthy subjects. In this study type 2 diabetes mellitus patients showed a significantly greater percentage decline in FVC, FEV1, FEF25-75%, PEFR, and a slight increase in the ratio of FEV1/FVC suggestive of the restrictive pulmonary disorder.
Conclusion: This study found the pulmonary functions FVC, FEV1, FEF25%-75%, and PEFR are decreased inType 2 diabetes mellitus compared to controls. FEV1/FVC% slightly increased in Type 2 diabetes mellitus, which is indicative of the restrictive pulmonary disorder.
Keywords: Diabetes Mellitus, Pulmonary Function Tests, Spirometer
1. Sushruta Samhita BD. 1-3 Calcutta,1907-16.
2. Expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of Diabetes mellitus. Diabetic Care, Suppl. 1, 2003; S5-S20.
3. Leahy JL. Beta-cell dysfunction in type 2 diabetes mellitus. In Khan RC editorsJoslin's Diabetes Medicine. 14th ed, 2005; 449-61.
4. Larsen, Kronenberg, Melmed, Polonsky. Williams textbook endocrinology. 10thed.Pennsylvania: Elsevier India Publisher 2003.
5. Carlos BA, Stern E, Kramer M, Lebzelter J, Blum I, Fink G. Pulmonary function in patients with diabetes mellitus. Am J Med Sci 2001;322(3):127-32.
6. Malcom S. Is the lung a target organ in diabetes mellitus? Arch Intern Med1990;150:1385-88.
7. Robert WE, Beiser A, Rachel J, Givelber, George T, O'Connor et al. Associationbetween glycemic state and lung function. Am J Respir Crit Care Med2003;167:911- 916.
8. Wendy DA, Knuiman M, Kendell P, Grange V, Davis TME. Glycemic exposureis associated with reduced pulmonary function in Type-2 diabetes. Diabetes Care2004;27:752- 757.
9. Timothy DM, Knuiman M, Kendell P, Vu H, Davis WA. Reduced pulmonaryfunction and its associations in type 2 diabetes: Diabetes Res Clin Pract2000;50:152-159.
10. Meo SA, Drees AMA, Ahmed J, Shah SFA, Al-R K, Husain A, Al-Ruben K. Effect of the duration of disease on ventilatory function in an ethnic Saudi group of diabetic patients. J Diabetics Sci Technol 2007;1(5):711-17.
11. Sreeja CK, Samuel E, Chandran CK, Shashidaran S. Pulmonary function in patients with diabetes mellitus. IJPP 2003;47(1):87-93.
Gautam R . A Comparative Study of Pulmonary Functions in Patients with Type 2 Diabetes Mellitus and Normal Individuals.Perspectives in Medical Research 2021; 9 (1):59-63 DOI:10.47799/pimr.0901.12